Davenport & Co’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $718K | Hold |
11,100
| – | – | ﹤0.01% | 876 |
|
|
2026
Q1 | $581K | Hold |
11,100
| – | – | ﹤0.01% | 877 |
|
|
2025
Q4 | $569K | Sell |
11,100
-474,312
| -98% | -$21.9M | ﹤0.01% | 861 |
|
|
2025
Q3 | $18.9M | Sell |
485,412
-200,225
| -29% | -$6.88M | 0.1% | 171 |
|
|
2025
Q2 | $20.8M | Sell |
685,637
-62,485
| -8% | -$1.79M | 0.12% | 155 |
|
|
2025
Q1 | $21.3M | Sell |
748,122
-21,349
| -3% | -$675K | 0.13% | 152 |
|
|
2024
Q4 | $25.4M | Sell |
769,471
-291
| -0% | -$11K | 0.15% | 140 |
|
|
2024
Q3 | $28.7M | Sell |
769,762
-1,138
| -0.1% | -$41.5K | 0.17% | 132 |
|
|
2024
Q2 | $25.7M | Sell |
770,900
-289
| -0% | -$9.68K | 0.16% | 136 |
|
|
2024
Q1 | $27.5M | Buy |
771,189
+83,403
| +12% | +$2.89M | 0.17% | 136 |
|
|
2023
Q4 | $22.7M | Sell |
687,786
-125
| -0% | -$3.36K | 0.16% | 134 |
|
|
2023
Q3 | $18.7M | Sell |
687,911
-3,242
| -0.5% | -$97.6K | 0.14% | 137 |
|
|
2023
Q2 | $21.8M | Buy |
691,153
+2,137
| +0.3% | +$66.4K | 0.16% | 131 |
|
|
2023
Q1 | $18.7M | Buy |
689,016
+77,616
| +13% | +$2.34M | 0.15% | 138 |
|
|
2022
Q4 | $18.5M | Buy |
+611,400
| New | +$18.4M | 0.15% | 136 |
|
|
2015
Q4 | – | Sell |
-42,587
| Closed | -$1.19M | – | 607 |
|
|
2015
Q3 | $1.19M | Buy |
+42,587
| New | +$1.49M | 0.02% | 248 |
|
Other funds holding SBIO
PFS
IFG
FEM
HIA
SWM